AG
NUVB icon

Algert Global’s Nuvation Bio NUVB Stock Holding History

Algert Global’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.9M Buy
1,842,078
+1,550,970
+533% +$8.64M 0.12% 281
2025
Q4 		$2.61M Buy
+291,108
New +$1.8M 0.04% 637
2025
Q3 		– Sell
-781,165
Closed -$1.52M – 1282
2025
Q2 		$1.52M Sell
781,165
-224,061
-22% -$467K 0.03% 709
2025
Q1 		$1.77M Buy
1,005,226
+133,757
+15% +$304K 0.04% 635
2024
Q4 		$2.32M Buy
871,469
+583,280
+202% +$1.5M 0.05% 553
2024
Q3 		$660K Sell
288,189
-138,414
-32% -$422K 0.02% 843
2024
Q2 		$1.25M Buy
426,603
+314,635
+281% +$960K 0.04% 621
2024
Q1 		$408K Buy
111,968
+44,868
+67% +$86.2K 0.02% 816
2023
Q4 		$101K Sell
67,100
-257,338
-79% -$331K ﹤0.01% 1073
2023
Q3 		$435K Buy
324,438
+6,421
+2% +$10.7K 0.02% 786
2023
Q2 		$572K Hold
318,017
– – 0.02% 789
2023
Q1 		$528K Buy
318,017
+116,540
+58% +$236K 0.02% 805
2022
Q4 		$387K Buy
201,477
+45,110
+29% +$91.3K 0.02% 876
2022
Q3 		$350K Buy
156,367
+119,097
+320% +$340K 0.02% 906
2022
Q2 		$121K Buy
37,270
+23,419
+169% +$102K 0.01% 1094
2022
Q1 		$73K Buy
+13,851
New +$77.8K ﹤0.01% 1125

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Algert Global's NUVB Position: Q1 2026 in Review

Algert Global increased its Nuvation Bio (NUVB) stake by 533% in Q1 2026, buying an estimated $8.64M and bringing the position to 1,842,078 shares worth $7.9M. The position accounts for 0.12% of the portfolio, ranked #281.

Algert Global first reported a position in NUVB in Q1 2022 and has held it in 16 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Algert Global held 1,842,078 shares of Nuvation Bio worth $7.9M as of Q1 2026.
  • Algert Global bought 1,550,970 Nuvation Bio shares in Q1 2026, an estimated $8.64M.
  • Nuvation Bio made up 0.12% of Algert Global's portfolio in Q1 2026, its #281 holding.
  • Algert Global first reported a position in Nuvation Bio in Q1 2022 and has held it in 16 quarters since.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.